CF
CPRX

Centaurus Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

Centaurus Financial’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$179K Buy
7,249
+100
+1% +$2.38K 0.01% 850
2025
Q4 		$167K Sell
7,149
-675
-9% -$15K 0.01% 863
2025
Q3 		$154K Buy
7,824
+150
+2% +$3.08K 0.01% 884
2025
Q2 		$167K Sell
7,674
-103
-1% -$2.43K 0.01% 784
2025
Q1 		$189K Buy
7,777
+37
+0.5% +$833 0.01% 689
2024
Q4 		$162K Sell
7,740
-1,795
-19% -$38.6K 0.01% 722
2024
Q3 		$190K Sell
9,535
-100
-1% -$1.85K 0.01% 653
2024
Q2 		$149K Sell
9,635
-200
-2% -$3.11K 0.01% 678
2024
Q1 		$157K Buy
+9,835
New +$148K 0.01% 665

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Centaurus Financial's CPRX Position: Q1 2026 in Review

Centaurus Financial increased its Catalyst Pharmaceutical (CPRX) stake by 1.4% in Q1 2026, buying an estimated $2.38K and bringing the position to 7,249 shares worth $179K. The position accounts for 0.01% of the portfolio, ranked #850.

Centaurus Financial first reported a position in CPRX in Q1 2024 and has held it in 9 quarters since. The position peaked at $190K in Q3 2024. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Centaurus Financial held 7,249 shares of Catalyst Pharmaceutical worth $179K as of Q1 2026.
  • Centaurus Financial bought 100 Catalyst Pharmaceutical shares in Q1 2026, an estimated $2.38K.
  • Catalyst Pharmaceutical made up 0.01% of Centaurus Financial's portfolio in Q1 2026, its #850 holding.
  • Centaurus Financial first reported a position in Catalyst Pharmaceutical in Q1 2024 and has held it in 9 quarters since.
  • Centaurus Financial's Catalyst Pharmaceutical position peaked at $190K in Q3 2024.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.